Hepatocellular carcinoma: Difference between revisions
| Line 27: | Line 27: | ||
==Treatment== | ==Treatment== | ||
[[Hepatocellular carcinoma medical therapy|Medical therapy]] | [[Hepatocellular carcinoma surgery|Surgical options]] | [[Hepatocellular carcinoma primary prevention|Primary prevention]] | [[Hepatocellular carcinoma secondary prevention|Secondary prevention]] | [[Hepatocellular carcinoma cost-effectiveness of therapy|Financial costs]] | [[Hepatocellular carcinoma future or investigational therapies|Future therapies]] | :[[Hepatocellular carcinoma medical therapy|Medical therapy]] | [[Hepatocellular carcinoma surgery|Surgical options]] | [[Hepatocellular carcinoma primary prevention|Primary prevention]] | [[Hepatocellular carcinoma secondary prevention|Secondary prevention]] | [[Hepatocellular carcinoma cost-effectiveness of therapy|Financial costs]] | [[Hepatocellular carcinoma future or investigational therapies|Future therapies]] | ||
== Awareness == | == Awareness == | ||
Revision as of 14:45, 23 December 2011
For patient information click here
| Hepatocellular carcinoma | |
 | |
|---|---|
| Hepatocellular Carcinoma, Hepatitis C positive. Tumor growth in portal vein | |
| ICD-10 | C22.0 |
| ICD-9 | 155 |
| ICD-O: | 8170/3 |
| MedlinePlus | 000280 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
|
Hepatocellular carcinoma Microchapters |
|
Differentiating Hepatocellular carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hepatocellular carcinoma On the Web |
|
American Roentgen Ray Society Images of Hepatocellular carcinoma |
|
Risk calculators and risk factors for Hepatocellular carcinoma |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Epidemiology & Demographics
Pathophysiology
Diagnosis
- History and Symptoms | Physical Examination | Staging | Lab Studies | Electrocardiogram | Chest X Ray | MRI | CT | Echocardiography | Other imaging findings
Treatment
- Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
Awareness
The Jade Ribbon Campaign is used for awareness of liver cancer in the Pacific Islands and will be introduced into America someday.
Jade is the official color of liver cancer.
Future directions
Current research includes the search for the genes that are disregulated in HCC,[1] protein markers[2], and other predictive biomarkers.[3][4] As similar research is yielding results in various other malignant diseases, it is hoped that identifying the aberrant genes and the resultant proteins could lead to the identification of pharmacological interventions for HCC.[5]
References
- ↑ Genetic research in HCC Stanford Asian Liver Center
- ↑ Huntington Medical Research Institute News, May 2005
- ↑ [1] Journal of Clinical Oncology, Special Issue on Molecular Oncology: Receptor-Based Therapy, April 2005
- ↑ Lau W, Leung T, Ho S, Chan M, Machin D, Lau J, Chan A, Yeo W, Mok T, Yu S, Leung N, Johnson P (1999). "Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial". Lancet. 353 (9155): 797–801. PMID 10459961.
- ↑ Thomas M, Zhu A (2005). "Hepatocellular carcinoma: the need for progress". J Clin Oncol. 23 (13): 2892–9. PMID 15860847.
External links
Template:Gastroenterology Template:Tumors Template:Tumor morphology de:Leberzellkarzinom fi:Maksasyöpä hr:Rak jetre hu:Májtumor la:Carcinoma hepatocellulare ko:간암 nl:Leverkanker no:Leverkreft sv:Levercancer